Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Patient rep: Sector can ensure 'dignified' discharge care

Healthwatch UK chair Anna Bradley has praised a project that used community pharmacists to reinforce medicines management among patients who have left hospital

A pilot in which community pharmacists assess discharged patients should be replicated across the country to ensure “dignified care”, Healthwatch UK has said.
 
The independent patient organisation had gathered “stories” from more than 3,200 patients discharged from hospital and concluded that there was a “lack of support” available to them, it said in a report published last week (July 21).
 
Patients also experienced “unsafe, delayed or untimely discharge due to a lack of co-ordination between health, social care and community services”, it stressed.
 
Healthwatch UK chair Anna Bradley told C+D yesterday (July 28) that rolling out the Isle of Wight reablement service was one solution.
 
According to PSNC's website, the project lauched in 2011 and involved community pharmacists visiting vulnerable discharged patients at home to offer further support and reinforce medicines advice given in hospital. This included conducting medicines use reviews (MURs) and checking the patient's medicines cabinet.

Ms Bradley said the pilot was one example of “especially good practice” and Healthwatch UK wanted to see similar projects “replicated across the system”. “Ensuring medicines management is part of discharge planning will result in a safer experience for thousands of people,” Ms Bradley said.

"Let down by the system"

In its report, Healthwatch UK focused on discharged patients who were elderly, homeless or had mental health issues. It concluded that they were “let down by the system” in five ways, including being excluded from decisions about their post-discharge care and feeling “rushed out of the door” after their time in hospital.
 
Ms Bradley said poor medicines management resulted in older people taking multiple drugs simultaneously, which could result in adverse reactions and readmission. “The key issue here is the breakdown of communication between patients and clinicians,” she stressed.

Healthwatch also used its report to highlight the work done by the Royal Pharmaceutical Society (RPS) to use fact sheets and videos to educate patients about managing their medicines when they changed care settings. 

In response to the report, North of Tyne LPC highlighted that it was still “working closely” with Newcastle Hospital Trust on a project to deliver “seamless care” to discharged patients. This involved messages about medicines adherence initially being given by hospital pharmacists and then reinforced in medicines reviews delivered by their community colleagues, the LPC said.
 


How do you care for discharged patients?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel